DKCM
SGHT icon

Davidson Kempner Capital Management’s Sight Sciences SGHT Stock Holding History

Davidson Kempner Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-27,000
Closed -$609K – 599
2021
Q3 		$609K Buy
+27,000
New +$888K 0.01% 332

Other funds holding SGHT

DCP
D1 Capital Partners New York $11.2B AUM 15.78% 1-Year Est. Return
KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Davidson Kempner Capital Management's SGHT Position: Q4 2021 in Review

Davidson Kempner Capital Management sold out of Sight Sciences (SGHT) in Q4 2021, closing a stake of 27,000 shares — an estimated $609K sold.

Davidson Kempner Capital Management first reported a position in SGHT in Q3 2021 and held it in 1 quarter. The position peaked at $609K in Q3 2021. 60 funds tracked by Wall St. Rank hold SGHT as of Q4 2021.

  • Davidson Kempner Capital Management reported no remaining Sight Sciences position as of Q4 2021 after selling out during the quarter.
  • Davidson Kempner Capital Management sold 27,000 Sight Sciences shares in Q4 2021, an estimated $609K.
  • Davidson Kempner Capital Management first reported a position in Sight Sciences in Q3 2021 and held it in 1 quarter.
  • Davidson Kempner Capital Management's Sight Sciences position peaked at $609K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Sight Sciences as of Q4 2021.

Based on Davidson Kempner Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.